About Medilife Impex Private Limited
Data last updated:
Medilife Impex Private Limited is a private limited company based in Hingna, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2012PTC228514. Its GSTIN is 27AAHCM8439M1ZR (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Fazle Qadir Abdealibhai Chimthanawala and Fidaequaem Yusuf Varawalla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No. M – 30 MIDC Industrial Area Nildoh Village, Hingna, Maharashtra, India – 440028.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.66 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Cr (net margin 6%) and EBITDA of ₹2.41 Cr (EBITDA margin 12.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.
The company has about 32 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹7 Cr on record. Court records list 7 cases involving the company, including 5 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medilifehomeo.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressP. No. M – 30 MIDC Industrial Area Nildoh Village, Hingna, Maharashtra, India – 440028
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medilife Impex Private Limited
The main business activity of Medilife Impex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medilife Impex Private Limited FY 2025 filings available
Medilife Impex Private Limited reported revenue of ₹18.66 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medilife Impex Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 3% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medilife Impex Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.41 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.12 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medilife Impex Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medilife Impex are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medilife Impex Private Limited
Medilife Impex Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Healthcare Products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indu Drugs Private Limited | ₹18.78 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Gulkas Pharma Pvt Ltd | ₹18.78 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Kalol, Gujarat, India |
| Anaesthetic Gases Pvt Ltd | ₹18.78 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Chandigarh, India |
| Teadus Pharma Private Limited | ₹18.7 Cr (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Gpax Pharmaceuticals Private Limited | ₹18.67 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Navi Mumbai, Maharashtra, India |
| Medilife Impex Private Limited this company | ₹18.66 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Hingna, Maharashtra, India |
| Aakash Pharma Private Limited | ₹18.62 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Madurai, Tamil Nadu, India |
| Sai Sarvaa Biotech Private Limited | ₹18.57 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Villupuram, Tamil Nadu, India |
| One Drip Healthcare Private Limited | ₹18.55 Cr (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Koye Lifesciences Private Limited | ₹18.55 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Mumbai, Maharashtra, India |
| Acinta Pharmaceuticals Private Limited | ₹18.54 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Medilife Impex by revenue in the Pharma industry (Formulations, Healthcare Products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medilife Impex Private Limited
Medilife Impex Private Limited is audited by AGRAWAL & KHANDELWAL for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AGRAWAL & KHANDELWAL | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medilife Impex Private Limited
Medilife Impex has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Fazle Qadir Abdealibhai Chimthanawala | Director | 07 Nov 2019 | 6 Years 11 Months | Current |
| Fidaequaem Yusuf Varawalla Also directs: Xenicon Ventures Private Limited | Director | 20 Mar 2012 | 14 Years 6 Months | Current |
| Sadque Razzak Chimthanawala | Director | 11 Sep 2025 | 1 Years 0 Months | Current |
Ownership and Shareholding of Medilife Impex Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medilife Impex Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2024 | Others | ₹3 Cr | Open |
| 11 Jan 2016 | Canara Bank | ₹3 Cr | Satisfied |
| 17 Jan 2014 | Canara Bank | ₹4 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Medilife Impex Private Limited
Medilife Impex Private Limited has 7 court cases on record: 5 filed by Medilife Impex, 1 filed against it, 1 where it is another party. 2 cases are pending and 5 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 1 |
| Supreme Court | 2 | 1 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Criminal miscellaneous application | Filed by the company against an individual | Pending |
| Supreme Court | Court case (T.C.(C)) | Filed by the company against Union of India | Pending |
| District court, Nagpur, Maharashtra | Court case (M.A.C.P.) | Company is another party | Disposed |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against Ashalan Homoeopathic Pharmacy | Disposed |
| Supreme Court | Court case (T.P.(C)) | Filed against the company by Union of India | Disposed |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Medilife Impex Private Limited
Medilife Impex Private Limited has a workforce of 32 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medilife Impex Private Limited
Medilife Impex Private Limited has 6 board changes on record since 2012: 3 appointments and 3 cessations. The latest: Sadque Razzak Chimthanawala ceased to be Additional Director on 29 Sep 2025.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Medilife Impex Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medilife Impex Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medilife Impex Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medilife Impex Private Limited
Medilife Impex has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM8439M1ZR | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medilife Impex Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medilife Impex Private Limited
Medilife Impex is an active private limited company based in Hingna, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2012 (14+ years old) and is registered under CIN U51101MH2012PTC228514.
Medilife Impex reported revenue of ₹18.66 Cr for FY 2025 (up 3% YoY).
Medilife Impex has 3 current directors:
- Fazle Qadir Abdealibhai Chimthanawala - Director
- Fidaequaem Yusuf Varawalla - Director
- Sadque Razzak Chimthanawala - Director
Medilife Impex reported a net profit of ₹1.12 Cr (net margin 6%) and EBITDA of ₹2.41 Cr (EBITDA margin 12.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medilife Impex is 9% over three years and 7% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medilife Impex is 27AAHCM8439M1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medilife Impex is U51101MH2012PTC228514. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medilife Impex has 7 court cases on record: 5 filed by the company and 1 filed against it. 2 are pending. Most are in the district courts.
Medilife Impex was incorporated on 20 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medilife Impex by revenue are Indu Drugs Private Limited, Gulkas Pharma Pvt Ltd, Anaesthetic Gases Pvt Ltd, Teadus Pharma Private Limited, Gpax Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Healthcare Products).
Sadque Razzak Chimthanawala ceased to be Additional Director on 29 Sep 2025. Sadque Razzak Chimthanawala was appointed as Director on 11 Sep 2025. Fazle Qadir Abdealibhai Chimthanawala ceased to be Additional Director on 31 Dec 2020. Medilife Impex has 6 board changes on record in total.